Active surveillance for low-risk prostate cancer: an update

被引:0
|
作者
Nathan Lawrentschuk
Laurence Klotz
机构
[1] Austin Hospital,Ludwig Institute for Cancer Research and University of Melbourne Department of Surgery
[2] University of Toronto,Department of Surgery, Division of Urology
[3] Sunnybrook Health Sciences Centre,undefined
来源
Nature Reviews Urology | 2011年 / 8卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Active surveillance is now an accepted management strategy for men with low-risk localized prostate cancer. Here, Lawrentschuk and Klotz provide an overview of the current issues concerning this somewhat contentious regime, including how best to select patients for active surveillance, which criteria should prompt intervention, and the concept of secondary chemoprevention.
引用
收藏
页码:312 / 320
页数:8
相关论文
共 50 条
  • [1] Active surveillance for low-risk prostate cancer: an update
    Lawrentschuk, Nathan
    Klotz, Laurence
    [J]. NATURE REVIEWS UROLOGY, 2011, 8 (06) : 312 - 320
  • [2] Active Surveillance for Low-risk Prostate Cancer
    Mazzucchelli, Roberta
    Nesseris, Ioannis
    Cheng, Liang
    Lopez-Beltran, Antonio
    Montironi, Rodolfo
    Scarpelli, Marina
    [J]. ANTICANCER RESEARCH, 2010, 30 (09) : 3683 - 3692
  • [3] Active Surveillance for Low-Risk Prostate Cancer
    Laurence Klotz
    [J]. Current Urology Reports, 2015, 16
  • [4] Active surveillance for low-risk prostate cancer
    Klotz, Laurence
    [J]. CURRENT OPINION IN UROLOGY, 2017, 27 (03) : 225 - 230
  • [5] Active surveillance for low-risk prostate cancer
    Herlemann, Annika
    Stief, Christian G.
    [J]. UROLOGE, 2016, 55 (02): : 269 - 278
  • [6] Active Surveillance for Low-Risk Prostate Cancer
    Klotz, Laurence
    [J]. CURRENT UROLOGY REPORTS, 2015, 16 (04) : 1 - 10
  • [7] Active surveillance for low-risk prostate cancer
    Bangma, Chris H.
    Bul, Meelan
    van der Kwast, Theo H.
    Pickles, Tom
    Korfage, Ida J.
    Hoeks, Caroline M.
    Steyerberg, Ewout W.
    Jenster, Guido
    Kattan, Michael W.
    Bellardita, Lara
    Carroll, Peter R.
    Denis, Louis J.
    Parker, Chris
    Roobol, Monique J.
    Emberton, Mark
    Klotz, Laurence H.
    Rannikko, Antti
    Kakehi, Yoshiyuki
    Lane, Janet A.
    Schroder, Fritz H.
    Semjonow, Axel
    Trock, Bruce J.
    Valdagni, Riccardo
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 85 (03) : 295 - 302
  • [8] Active surveillance for low-risk prostate cancer
    Hadjipavlou, Marios
    Promponas, John
    Madaan, Sanjeev
    [J]. JOURNAL OF CLINICAL UROLOGY, 2015, 8 (06) : 420 - 428
  • [9] Active surveillance preferred for low-risk prostate cancer
    Bagcchi, Sanjeet
    [J]. LANCET ONCOLOGY, 2015, 16 (08): : E384 - E384
  • [10] Is There a Role for Active Surveillance in Low-Risk Prostate Cancer?
    Augustin, Herbert
    Mayerhofer, Katrin
    Seles, Maximilian
    Pummer, Karl
    [J]. UROLOGIA INTERNATIONALIS, 2015, 95 (02) : 125 - 131